1,220
Participants
Start Date
May 21, 2024
Primary Completion Date
March 31, 2028
Study Completion Date
March 31, 2028
OAC will be discontinued for the duration of the trial
Discontinuation of warfarin, dabigatran, rivaroxaban, apixaban or edoxaban
NOT_YET_RECRUITING
Rigshospitalet, Copenhagen
RECRUITING
Gentofte Hospital, Gentofte Municipality
NOT_YET_RECRUITING
Regionshospital Gødstrup, Herning
NOT_YET_RECRUITING
Aalborg university hospital, Aalborg
RECRUITING
Århus Universitetshospital, Aarhus
RECRUITING
Odense University Hospital, Odense
Collaborators (1)
Rigshospitalet, Denmark
OTHER
Gødstrup Hospital
OTHER
Aarhus University Hospital
OTHER
Aalborg University Hospital
OTHER
Population Health Research Institute
OTHER
Region of Southern Denmark
OTHER
Odense University Hospital
OTHER